OAG
LLY icon

Oakmont Advisory Group’s Eli Lilly LLY Stock Holding History

Oakmont Advisory Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$418K Buy
348
+19
+6% +$19.4K 0.35% 67
2026
Q1 		$303K Buy
+329
New +$334K 0.31% 100

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Oakmont Advisory Group's LLY Position: Q2 2026 in Review

Oakmont Advisory Group increased its Eli Lilly (LLY) stake by 5.8% in Q2 2026, buying an estimated $19.4K and bringing the position to 348 shares worth $418K. The position accounts for 0.35% of the portfolio, ranked #67.

Oakmont Advisory Group first reported a position in LLY in Q1 2026 and has held it in 2 quarters since. 4,594 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Oakmont Advisory Group held 348 shares of Eli Lilly worth $418K as of Q2 2026.
  • Oakmont Advisory Group bought 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
  • Eli Lilly made up 0.35% of Oakmont Advisory Group's portfolio in Q2 2026, its #67 holding.
  • Oakmont Advisory Group first reported a position in Eli Lilly in Q1 2026 and has held it in 2 quarters since.
  • 4,594 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Oakmont Advisory Group's 13F filing for Q2 2026, filed 3 Aug 2026.